The group behind the leading public exchange-traded fund (ETF) for the Canadian cannabis industry on Monday (June 18) updated its lineup of ETFs with exposure to cannabis stocks.

Horizons ETFs Management revealed plans to list futures contracts for the Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) and to launch three new “inverse and inverse leveraged ETFs.”

According to the Globe and Mail, leveraged ETFs are also commonly known as double ETFs and seek to provide investors with “two or three times the return on their stated index.” However, these have a higher risk than the more traditional index.

Horizons said the futures contracts on HMMJ will start trading on Monday on the Montreal Exchange and will have quarterly expiration dates for January, March, June and September with an initial extension to a June 2019 expiry.

“For us, this further legitimizes Marijuana-equity investing and HMMJ as the key way to get broad index exposure to this rapidly growing sector,” said Steve Hawkins, president and co-CEO of Horizons ETFs.

Overview of the new proposed ETFs

The information for the three new proposed ETFs isn’t final, but as of Monday is listed as:

  • BetaPro Canadian Marijuana Companies 2x Daily Bull ETF (HMJU): Seeks daily investment results. Before established costs, this ETF will look to correspond two times the daily performance of the Solactive Canadian Marijuana Companies Index.
  • BetaPro Canadian Marijuana Companies -2x Daily Bear ETF (HMJD): This new ETF will also compare itself to the Solactive index but will seek to create two times the opposite of its daily performance.
  • BetaPro Canadian Marijuana Companies Inverse ETF (HMJI): Similarly HMJI will use the Solactive index as a comparison, except this ETF will seek to correspond one time the inverse of the daily performance of Solactive.

Hawkins said Horizons believes there is demand for a riskier option by way of leveraged ETFs that create “higher short-term returns.”

Horizons estimates HMJI and HMJD will carry a hedging cost between 10 and 25 percent per year of the aggregate notional exposure. This cost is credited to the high price of borrowing securities from cannabis companies.

“If used appropriately, inverse marijuana ETFs could be a potentially more liquid and easier way for investors to get short exposure to Canadian-listed marijuana stocks while limiting their risk to what they invested,” Hawkins cautioned.

Horizons plans to stick with the law when it comes to exposure to US stocks or even recreational Canadian stocks until cannabis becomes fully legal. On the changes needed for the ETFs to allow US exposure Horizons wrote:

Unless and until the US Congress amends the US Controlled Substances Act with respect to cannabis, there is a risk that federal authorities may enforce current U.S. federal law against businesses operating in the U.S. cannabis industry, which may adversely affect the market price of any constituent issuers that have exposure to the US cannabis industry, and therefore the value of a New ETF

Horizons explained that if a constituent from one of its indexes gets delisted from the Toronto Stock Exchange or TSX Venture because of breaching the guidelines from these TMX Group exchanges then it will also be removed from the index.

“Any security imbalances caused by material rebalances or trading halts can affect the marked-to-market value of the forward documents negatively on any given day in relation to the closing level of the underlying index,” Horizons wrote.

Horizons started the first ETF focused exclusively on cannabis stocks, HMMJ, which has some of the biggest licensed producers as its top holdings. So far in 2018 HMMJ has seen a 4.71-percent decline in value and is currently priced at C$18.54. In March, HMMJ added 10 more cannabis listings for the overall index, bringing it to a total of 40 stocks.

Horizons also launched an additional ETF in February, the Emerging Marijuana Growers Index ETF (AQN:HMJR), which has a focus on smaller-cap producers of cannabis.

“HMJR will exclusively invest in marijuana growers that, in our view, are well-positioned to take part in the global growth of the marijuana sector,” Hawkins said in a statement from the Aequitas NEO Exchange. HMJR is currently priced at $C8.25.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced the hiring of CPG industry veteran Ty Gent as the Company’s new Chief Operating Officer (“COO”). As COO, Gent will be responsible for operational consistency and efficiency across markets and implementation of structural enhancements to facilitate scaling.

This press release features multimedia. View the full release here:

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (“ HempFusion ” or the “ Company ”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its wholly owned subsidiary, Probulin Probiotics, LLC (“ Probulin ”), has increased its product selection in certain brick and mortar locations and expanded its distribution on Amazon through a unique eCommerce store within the Amazon platform. The broader product selection is available in major brick and mortar stores including Sprouts and Fresh Thyme and includes the Company’s new Probulin Total Care Immune product.

This press release features multimedia. View the full release here:

Keep reading... Show less

 MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to report third party confirmatory studies that the active ingredient in MustGrow’s mustard plant-based technology, Allyl Isothiocyanate (“AITC”), has a positive impact on soil health, contributing to the environmental and ecological security of both our plant-based food supply and the planet. Application of natural AITC returns organic plant material to the soil through its pre-plant treatment process as a potential alternative to using synthetic chemicals.

Soil micro-organisms play an important role in soil fertility and plant health, contributing to natural soil processes including the formation of organic matter and nutrient transformation. Human activities, including chemical pesticide use, can adversely impact the soil microbial diversity and structure.

Keep reading... Show less

Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), today announced that its subsidiary CannaCure Corp. (“CannaCure”) has entered into a binding letter of intent with Entourage Participações S.A. (“Entourage Phytolab”) for a three-year extraction and finished product supply agreement (the “Agreement”) for the distribution of pharmaceutical products in Brazil.

Under the terms of the Agreement, Heritage will supply to Entourage Phytolab, hemp-derived CBD dominant extract, cannabis-derived THC dominant extract, and hemp-derived CBD 25 mg softgels and cannabis-derived THC dominant 2.5 and 5.0 mg softgels.

Keep reading... Show less

Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) Is pleased to announce its partially owned subsidiary NeonMind (CSE: NEON) (“NeonMind”) has common shares now trading on the Frankfurt Stock Exchange (the “FSE”) under the symbol “6UF”. As a result, NeonMind’s common shares are now cross-listed on the Canadian Securities Exchange and the FSE. Shares of Better Plant are available on the FSE under the symbol “YG3”.

Cannot view this image? Visit:

Keep reading... Show less